The relation of C--reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study

Ervin R Fox1, Emelia J Benjamin, Daniel F Sarpong

  • 1Department of Medicine, University of Mississippi School of Medicine, Jackson, MS, USA. efox@medicine.umsmed.edu

BMC Nephrology
|January 19, 2010
PubMed

Insights

Inflammation marker C-reactive protein (CRP) is linked to chronic kidney disease (CKD) in African Americans. Further research is needed to understand inflammation

Area of Science:

  • Nephrology
  • Immunology
  • Public Health

Background:

  • African Americans exhibit higher chronic kidney disease (CKD) incidence and worse prognosis compared to European-descent populations.
  • Inflammation's role in renal dysfunction is established in other groups, but data specific to African Americans in community settings are limited.

Purpose of the Study:

  • To investigate the cross-sectional relationship between C-reactive protein (CRP) and renal function in African American adults.
  • To assess the association of CRP with chronic kidney disease (CKD) and albuminuria within this population.

Main Methods:

  • Utilized data from the Jackson Heart Study (2000-2004) including 4320 African American participants.
  • Employed multivariable linear regression to analyze the association of log-transformed CRP with estimated glomerular filtration rate (eGFR).
  • Adjusted for numerous covariates including age, sex, BMI, blood pressure, diabetes, lipids, and cardiovascular disease.

Main Results:

  • A significant association was found between higher CRP concentrations and the presence of CKD (p < 0.0001).
  • CRP was significantly associated with albuminuria in initial models, but this association did not persist after multivariable adjustment (p > 0.05).
  • The prevalence of CKD was 5.2% (228 cases) among the study participants.

Conclusions:

  • C-reactive protein (CRP) is associated with chronic kidney disease (CKD) in African Americans.
  • The link between CRP and albuminuria was not significant in multivariable analyses.
  • Further investigation into the role of inflammation in the progression of renal disease among African Americans is warranted.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...